Oxygen therapy in suspected acute myocardial infarction and concurrent normoxemic chronic obstructive pulmonary disease: a prespecified subgroup analysis from the DETO2X-AMI trial
暂无分享,去创建一个
B. Lindahl | T. Jernberg | J. Herlitz | S. James | D. Erlinge | T. Yndigegn | J. Pernow | P. Andell | R. Hofmann | D. Sparv | O. Östlund | David Sparv | Robin Hofmann
[1] B. Lindahl,et al. Long-Term Effects of Oxygen Therapy on Death or Hospitalization for Heart Failure in Patients With Suspected Acute Myocardial Infarction , 2018, Circulation.
[2] E. Omerovic,et al. The Analgesic Effect of Oxygen in Suspected Acute Myocardial Infarction: A Substudy of the DETO2X-AMI Trial. , 2018, JACC. Cardiovascular interventions.
[3] L. Svensson,et al. Oxygen therapy in ST-elevation myocardial infarction , 2018, European heart journal.
[4] Marco Valgimigli,et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). , 2018, European heart journal.
[5] S. Koul,et al. Outcome of patients with chronic obstructive pulmonary disease and severe coronary artery disease who had a coronary artery bypass graft or a percutaneous coronary intervention , 2017, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[6] L. Svensson,et al. Oxygen Therapy in Suspected Acute Myocardial Infarction , 2017, The New England journal of medicine.
[7] K. Rothnie,et al. Chronic obstructive pulmonary disease and acute myocardial infarction: effects on presentation, management, and outcomes , 2016, European heart journal. Quality of care & clinical outcomes.
[8] J. Smith,et al. β‐Blocker Use and Mortality in COPD Patients After Myocardial Infarction: A Swedish Nationwide Observational Study , 2015, Journal of the American Heart Association.
[9] M. Keltai,et al. Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes and Chronic Obstructive Pulmonary Disease: An Analysis From the Platelet Inhibition and Patient Outcomes (PLATO) Trial , 2015, Journal of the American Heart Association.
[10] B. Lindahl,et al. Type 2 myocardial infarction in clinical practice , 2014, Heart.
[11] Alana D. Steffen,et al. Sensitivity, Specificity, and Sex Differences in Symptoms Reported on the 13‐Item Acute Coronary Syndrome Checklist , 2014, Journal of the American Heart Association.
[12] L. Svensson,et al. DETermination of the role of OXygen in suspected Acute Myocardial Infarction trial. , 2014, American heart journal.
[13] J. Smith,et al. Impact of chronic obstructive pulmonary disease on morbidity and mortality after myocardial infarction , 2013, Open Heart.
[14] K. Bhaskaran,et al. Effect of β blockers on mortality after myocardial infarction in adults with COPD: population based cohort study of UK electronic healthcare records , 2013, BMJ.
[15] J. Hallas,et al. Classification of myocardial infarction: frequency and features of type 2 myocardial infarction. , 2013, The American journal of medicine.
[16] W. F. Abdo,et al. Oxygen-induced hypercapnia in COPD: myths and facts , 2012, Critical Care.
[17] G. Engström,et al. Validation of a COPD diagnosis from the Swedish Inpatient Registry , 2012, Scandinavian journal of public health.
[18] Patrick D Mitchell,et al. Hypoxemia in patients with COPD: cause, effects, and disease progression , 2011, International journal of chronic obstructive pulmonary disease.
[19] L. Sinoway,et al. Revisiting the role of oxygen therapy in cardiac patients. , 2010, Journal of the American College of Cardiology.
[20] A. Alsheikh-Ali,et al. Prevalence and Prognosis of Chronic Obstructive Pulmonary Disease Among 8167 Middle Eastern Patients With Acute Coronary Syndrome , 2010, Clinical cardiology.
[21] L. Wallentin,et al. Abstract 1428: Statin Use After Myocardial Iinfarction Improves Survival in Nearly All With Renal Dysfunction: Data From the Swedish Web-system for Enhancement and Development of Evidence-based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART) , 2009 .
[22] L. Wallentin,et al. Influence of Renal Function on the Effects of Early Revascularization in Non–ST-Elevation Myocardial Infarction: Data From the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART) , 2009, Circulation.
[23] B. Celli. Update on the management of COPD. , 2008, Chest.
[24] W. Bailey,et al. Long-term oxygen treatment in chronic obstructive pulmonary disease: recommendations for future research: an NHLBI workshop report. , 2006, American journal of respiratory and critical care medicine.
[25] J. Zweier,et al. The role of oxidants and free radicals in reperfusion injury. , 2006, Cardiovascular research.
[26] R. Hancox,et al. Elevation of cardiac troponins in exacerbation of chronic obstructive pulmonary disease. , 2004, Emergency medicine Australasia : EMA.
[27] R. F. Kelly,et al. Effect of 100% oxygen administration on infarct size and left ventricular function in a canine model of myocardial infarction and reperfusion. , 1995, American heart journal.
[28] N. Madias,et al. Precordial ST‐segment Mapping: 2. Effects of Oxygen Inhalation on Ischemic Injury in Patients with Acute Myocardial Infarction , 1976, Circulation.
[29] E. Braunwald,et al. Reduction of Infarct Size by Oxygen Inhalation Following Acute Coronary Occlusion , 1975, Circulation.